Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.

This study is not yet recruiting. It focuses on schizophrenia and currently lists study information in Canada.
Leave your email and HopeStage can help you better understand this study.
This observational study is following people with Psychosis, Schizophrenia Disorders, Bipolarity, or depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information. This study may not offer a new treatment, and its main value is helping researchers learn from follow-up information that may improve future care.
The official record suggests in-person participation through a university, with sites including Douglas Mental Health University Institute in Montreal. Participation appears to center on assessments, scans, or samples rather than trying a new treatment. Common reasons not to take part include pregnancy or breastfeeding. The official record does not list a trial phase, which usually means the study is focused on observation rather than testing a staged treatment.
This study may matter because it adds public evidence around schizophrenia. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
Taking part may help clarify how this condition is measured or understood.
It requires regular follow-up, often through questionnaires or interviews.
Requires travel, with in-person participation in Canada.
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
This study is exploring observational follow-up for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
This study is sponsored by Douglas Mental Health University Institute. Based on the sponsor name or official registry information, it appears to be a university. You should verify the details in the official registry record.
This study may involve observational follow-up, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me